SD Biosensor Inc (137310) Stock Price & News

137310:KRX

SD Biosensor Inc

₩7,110.00

+0.42%

(+30.00) 1D

Jun 10, 3:30:26 PM GMT+9 · KRW

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 137310...

Open

₩7,000

High

₩7,260

Low

₩6,870

Mkt. cap

858.53B

Avg. vol.

146.28K

Volume

90.29K

Dividend

2.81%

Quarterly dividend

₩50

Ex-dividend date

Dec 27, 2023

52-wk high

₩12,110

52-wk low

₩6,650

EPS

-₩3,937

Shares outstanding

120.75M

Open

₩7,000

High

₩7,260

Low

₩6,870

Mkt. cap

858.53B

Avg. vol.

146.28K

Volume

90.29K

Dividend

2.81%

Quarterly dividend

₩50

Ex-dividend date

Dec 27, 2023

52-wk high

₩12,110

52-wk low

₩6,650

EPS

-₩3,937

Shares outstanding

120.75M

Related stocks

News stories

From sources across the web

Simply Wall Street

31 minutes ago

Is Alignment Healthcare's (ALHC) Governance Shake-Up Quietly Redefining Its Long-Term Strategic Ambitions?

24/7 Wall St.

11 minutes ago

RSP vs. SPY: Does Equal Weight Beat the Cap-Weighted S&P 500?

Yahoo Finance

1 hour ago

Citi Sees the S&P 500 Hitting 8,100 – 2 ‘Strong Buy’ AI Stocks It Says Could Surge Alongside It

CNBC

4 hours ago

Autonomous EV freight trucking company Einride rises sharply in first trade on Nasdaq

About SD Biosensor Inc

CEO-

Employees-

Founded1999

Headquarters-

SectorMedical device

Websitesdbiosensor.co.kr

All values in KRW	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	166.50B	164.19B	194.57B	193.53B
Cost of goods sold	88.10B	85.03B	123.13B	94.24B
Cost of revenue	88.10B	85.03B	123.13B	94.24B
Research and development expenses	18.36B	18.73B	23.20B	22.30B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	54.03B	47.51B	56.88B	66.56B
Operating expense	99.75B	93.12B	104.42B	112.80B
Total operating expenses	187.84B	178.15B	227.55B	207.05B
Operating income	-21.34B	-13.96B	-32.98B	-13.52B
Other non operating income	-20.51B	2.79B	-385.04M	1.31B
EBT including unusual items	-67.08B	-12.16B	-816.03B	19.91B
EBT excluding unusual items	-72.76B	-14.44B	-59.71B	14.29B
Income tax expense	-342.21B	-2.24B	-56.22B	-2.42B
Effective tax rate	510.17%	18.45%	6.89%	-12.13%
Other operating expenses	1.34B	1.71B	2.50B	1.30B
Net income	275.23B	-9.72B	-758.94B	22.70B
Net profit margin	165.30%	-5.92%	-390.07%	11.73%
Earnings per share	-	-	-	-
Interest and investment income	3.61B	6.85B	6.77B	5.29B
Interest expense	-17.37B	-17.18B	-56.19B	-10.89B
Net interest expenses	-13.76B	-10.34B	-49.42B	-5.59B
Depreciation and amortization charges	3.21B	3.43B	3.68B	4.18B
EBITDA	13.76B	20.75B	-1.73B	15.88B
Gain or loss from assets sale	-8.48B	266.35M	1.62B	514.10M

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research